28056024|t|A Double-Blind Randomized Controlled Trial of Maternal Postpartum Deworming to Improve Infant Weight Gain in the Peruvian Amazon
28056024|a|Nutritional interventions targeting the critical growth and development period before two years of age can have the greatest impact on health trajectories over the life course. Compelling evidence has demonstrated that interventions investing in maternal health in the first 1000 days of life are beneficial for both mothers and their children. One such potential intervention is deworming integrated into maternal postpartum care in areas where soil - transmitted helminth (STH) infections are endemic. From February to August 2014, 1010 mother - infant pairs were recruited into a trial aimed at assessing the effectiveness of maternal postpartum deworming on infant and maternal health outcomes. Following delivery, mothers were randomly assigned to receive either single- dose 400 mg albendazole or placebo. Participants were followed-up at 1 and 6 months postpartum. There was no statistically significant difference in mean weight gain between infants in the experimental and control groups (mean difference: -0.02; 95% CI: -0.1, 0.08) at 6 months of age. Further, deworming had no effect on measured infant morbidity indicators. However, ad hoc analyses restricted to mothers who tested positive for STHs at baseline suggest that infants of mothers in the experimental group had greater mean length gain in cm (mean difference: 0.8; 95% CI: 0.1, 1.4) and length-for-age z-score (mean difference: 0.5; 95% CI: 0.2, 0.8) at 6 months of age. In a study population composed of both STH-infected and uninfected mothers, maternal postpartum deworming was insufficient to impact infant growth and morbidity indicators up to 6 months postpartum. Among STH-infected mothers, however, important improvements in infant length gain and length-for-age were observed. The benefits of maternal postpartum deworming should be further investigated in study populations having higher overall prevalences and intensities of STH infections and, in particular, where whipworm and hookworm infections are of public health concern. ClinicalTrials.gov (NCT01748929).
28056024	2	14	Double-Blind	T062	C0013072
28056024	15	42	Randomized Controlled Trial	T062	C0206035
28056024	46	65	Maternal Postpartum	T047	C0157460
28056024	66	75	Deworming	T061	C0199859
28056024	87	93	Infant	T100	C0021270
28056024	94	105	Weight Gain	T033	C0043094
28056024	113	121	Peruvian	T098	C1553375
28056024	129	154	Nutritional interventions	T061	C0086153
28056024	169	177	critical	T080	C1511545
28056024	178	207	growth and development period	T033	C1397007
28056024	228	231	age	T032	C0001779
28056024	264	270	health	T078	C0018684
28056024	271	283	trajectories	T079	C0750729
28056024	293	304	life course	T079	C1510618
28056024	317	325	evidence	T078	C3887511
28056024	348	361	interventions	T061	C0808232
28056024	375	390	maternal health	T081	C0024921
28056024	409	413	days	T079	C0439228
28056024	417	421	life	T078	C0376558
28056024	446	453	mothers	T099	C0026591
28056024	464	472	children	T099	C0680063
28056024	493	505	intervention	T061	C0808232
28056024	509	518	deworming	T061	C0199859
28056024	535	559	maternal postpartum care	UnknownType	C0545491
28056024	563	568	areas	T082	C0205146
28056024	575	579	soil	T167	C0037592
28056024	582	593	transmitted	T169	C0332289
28056024	594	602	helminth	T204	C0018893
28056024	604	607	STH	T204	C0018893
28056024	609	619	infections	T047	C0018889
28056024	624	631	endemic	T047	C0277550
28056024	638	646	February	T080	C3830166
28056024	650	656	August	T080	C3831448
28056024	668	674	mother	T099	C0026591
28056024	677	683	infant	T100	C0021270
28056024	712	717	trial	T062	C0008976
28056024	727	736	assessing	T058	C0220825
28056024	741	754	effectiveness	T080	C1280519
28056024	758	777	maternal postpartum	T047	C0157460
28056024	778	787	deworming	T061	C0199859
28056024	791	797	infant	T100	C0021270
28056024	802	817	maternal health	T081	C0024921
28056024	818	826	outcomes	T080	C0085415
28056024	828	837	Following	T079	C0332282
28056024	838	846	delivery	T040	C0005615
28056024	848	855	mothers	T099	C0026591
28056024	905	909	dose	T081	C0178602
28056024	917	928	albendazole	T109,T121	C0001911
28056024	932	939	placebo	T122	C1696465
28056024	941	953	Participants	T098	C0679646
28056024	959	970	followed-up	T058	C1522577
28056024	974	975	1	T079	C4082115
28056024	980	988	6 months	T079	C4082120
28056024	989	999	postpartum	T079	C0086839
28056024	1011	1039	no statistically significant	T033	C1273937
28056024	1040	1050	difference	T081	C1705241
28056024	1059	1070	weight gain	T033	C0043094
28056024	1079	1086	infants	T100	C0021270
28056024	1094	1106	experimental	T101	C0237950
28056024	1111	1125	control groups	T096	C0009932
28056024	1127	1142	mean difference	T081	C0392762
28056024	1155	1157	CI	T081	C0009667
28056024	1174	1182	6 months	T079	C4082120
28056024	1186	1189	age	T032	C0001779
28056024	1200	1209	deworming	T061	C0199859
28056024	1214	1223	no effect	T080	C1301751
28056024	1236	1252	infant morbidity	T046	C0848889
28056024	1253	1263	indicators	T081,T170	C0018761
28056024	1274	1289	ad hoc analyses	T081,T170	C0026348
28056024	1304	1311	mothers	T099	C0026591
28056024	1323	1331	positive	T033	C1514241
28056024	1336	1340	STHs	T204	C0018893
28056024	1344	1352	baseline	T081	C1442488
28056024	1366	1373	infants	T100	C0021270
28056024	1377	1384	mothers	T099	C0026591
28056024	1428	1434	length	T032	C0005890
28056024	1435	1439	gain	T081	C1517378
28056024	1447	1462	mean difference	T081	C0392762
28056024	1473	1475	CI	T081	C0009667
28056024	1491	1513	length-for-age z-score	T081	C0449820
28056024	1515	1530	mean difference	T081	C0392762
28056024	1541	1543	CI	T081	C0009667
28056024	1558	1566	6 months	T079	C4082120
28056024	1570	1573	age	T032	C0001779
28056024	1580	1596	study population	T098	C2348561
28056024	1614	1626	STH-infected	T047	C0018889
28056024	1631	1641	uninfected	T080	C3898900
28056024	1642	1649	mothers	T099	C0026591
28056024	1651	1670	maternal postpartum	T047	C0157460
28056024	1671	1680	deworming	T061	C0199859
28056024	1685	1697	insufficient	T080	C0231180
28056024	1708	1714	infant	T100	C0021270
28056024	1715	1721	growth	T040	C0018270
28056024	1726	1735	morbidity	T046	C0848889
28056024	1736	1746	indicators	T081,T170	C0018761
28056024	1753	1761	6 months	T079	C4082120
28056024	1762	1772	postpartum	T079	C0086839
28056024	1780	1792	STH-infected	T047	C0018889
28056024	1793	1800	mothers	T099	C0026591
28056024	1837	1843	infant	T100	C0021270
28056024	1860	1874	length-for-age	T033	C0517420
28056024	1906	1925	maternal postpartum	T047	C0157460
28056024	1926	1935	deworming	T061	C0199859
28056024	1970	1987	study populations	T098	C2348561
28056024	2010	2021	prevalences	T081	C0033105
28056024	2026	2037	intensities	T185	C4049786
28056024	2041	2055	STH infections	T047	C0018889
28056024	2082	2090	whipworm	T047	C0040954
28056024	2095	2114	hookworm infections	T047	C0019911
28056024	2122	2143	public health concern	T058	C0034024